AssureMDx analyzes DNA from exfoliated urothelial cells in urine to identify mutations (FGFR3, TERT, HRAS) and methylation changes (OTX1, ONECUT2, TWIST1), allowing for highly accurate detection of bladder cancer. This evidence concerns the gene TERT and urinary bladder carcinoma.